Hyperglycemia, hyperinsulinemia, and elevated resistin levels in both STAT5-deficient lines suggested hepatic insulin resistance upon STAT5 loss (Supporting Fig. 2A). This evidence concerns the gene STAT5B and hyperinsulinism.